RxDoctor Payments Data

Mary Cox, DO

Family Medicine · Charlotte, NCNPI 1649763632

Payments from drug & device makers

$496in general payments, 2019–2025

Across 30 payments — averaging $16.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$91
  • Abbott$52
  • Gilead$47
  • Novo Nordisk$43
  • Pfizer$43
  • Lilly USA, LLC$42
  • plus $178 from 8 others

What the payments were for

  • Food & beverage$496100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$496 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$18,046
Medicare patients
124
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide27$34,995
Repatha SureclickEvolocumab18$12,073
Rosuvastatin Calcium53$585
Ezetimibe26$412
Mirtazapine13$386
Irbesartan11$245
Levothyroxine Sodium25$241
Amlodipine Besylate24$220
Duloxetine Hcl15$191
Gabapentin24$160
Methylprednisolone26$148
Atorvastatin Calcium13$130
Metoprolol Succinate12$107
Azithromycin23$82
Losartan Potassium14$81

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$42$34,99527 claims
PfizerPaxlovid$43$012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →